{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:45:33Z","timestamp":1786992333460,"version":"build-2736575974"},"reference-count":21,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T00:00:00Z","timestamp":1528329600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.jfma.2018.06.005","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T08:58:25Z","timestamp":1529398705000},"page":"1124-1127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Clinical management of gamma-hydroxybutyrate (GHB) withdrawal delirium with CIWA-Ar protocol"],"prefix":"10.1016","volume":"117","author":[{"given":"Po-Chiao","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7616-8529","authenticated-orcid":false,"given":"Hu-Ming","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9241-1613","authenticated-orcid":false,"given":"Lian-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jfma.2018.06.005_bib1","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1592\/phco.21.20.1486.34472","article-title":"A comprehensive review of MDMA and GHB: two common club drugs","volume":"21","author":"Teter","year":"2001","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.jfma.2018.06.005_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.drugalcdep.2004.01.012","article-title":"Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review","volume":"75","author":"McDonough","year":"2004","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.jfma.2018.06.005_bib3","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1186\/s13063-016-1593-9","article-title":"Improving GHB withdrawal with baclofen: study protocol for a feasibility study for a randomised controlled trial","volume":"17","author":"Lingford-Hughes","year":"2016","journal-title":"Trials"},{"key":"10.1016\/j.jfma.2018.06.005_bib4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2458-9-27","article-title":"Use of ecstasy and other psychoactive substances among school-attending adolescents in Taiwan: national surveys 2004-2006","volume":"9","author":"Chen","year":"2009","journal-title":"BMC Publ Health"},{"issue":"1061","key":"10.1016\/j.jfma.2018.06.005_bib5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/postgradmedj-2012-131428","article-title":"Recreational drug use in men who have sex with men (MSM) attending UK sexual health services is significantly higher than in non-MSM","volume":"90","author":"Hunter","year":"2014","journal-title":"Postgrad Med"},{"issue":"5","key":"10.1016\/j.jfma.2018.06.005_bib6","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s10508-012-9908-8","article-title":"Online sex-seeking, substance use, and risky behaviors in Taiwan: results from the 2010 Asia Internet MSM Sex Survey","volume":"41","author":"Ko","year":"2012","journal-title":"Arch Sex Behav"},{"issue":"10","key":"10.1016\/j.jfma.2018.06.005_bib7","first-page":"29","article-title":"Delirium and antipsychotics: a systematic review of epidemiology and somatic treatment options","volume":"5","author":"Markowitz","year":"2008","journal-title":"Psychiatry"},{"issue":"1","key":"10.1016\/j.jfma.2018.06.005_bib8","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.drugalcdep.2006.01.002","article-title":"Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths","volume":"84","author":"Wu","year":"2006","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jfma.2018.06.005_bib9","series-title":"GHB and its precursor GBL: an emerging trend case study","author":"Addiction EMCfDaD","year":"2008"},{"key":"10.1016\/j.jfma.2018.06.005_bib10","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.drugpo.2017.07.003","article-title":"Differences in prevalence, socio-behavioral correlates, and psychosocial distress between club drug and hard drug use in Taiwan: results from the 2014 National Survey of Substance Use","volume":"48","author":"Chen","year":"2017","journal-title":"Int J Drug Policy"},{"issue":"1\u20133","key":"10.1016\/j.jfma.2018.06.005_bib11","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.drugalcdep.2011.07.016","article-title":"Patterns and levels of illicit drug use among men who have sex with men in Asia","volume":"120","author":"Wei","year":"2012","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"10.1016\/j.jfma.2018.06.005_bib12","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1124\/jpet.109.165381","article-title":"Concentration-effect relationships for the drug of abuse gamma-hydroxybutyric acid","volume":"333","author":"Felmlee","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.jfma.2018.06.005_bib13","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1067\/mem.2001.112985","article-title":"Gamma-hydroxybutyrate withdrawal syndrome","volume":"37","author":"Dyer","year":"2001","journal-title":"Ann Emerg Med"},{"issue":"1","key":"10.1016\/j.jfma.2018.06.005_bib14","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13049-017-0441-6","article-title":"Intoxication with GHB\/GBL: characteristics and trends from ambulance-attended overdoses","volume":"25","author":"Madah-Amiri","year":"2017","journal-title":"Scand J Trauma Resusc Emerg Med"},{"issue":"1","key":"10.1016\/j.jfma.2018.06.005_bib15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1360-0443.1997.tb03640.x","article-title":"Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence","volume":"92","author":"Galloway","year":"1997","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.jfma.2018.06.005_bib16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/1570159X13666141210215423","article-title":"GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome","volume":"13","author":"Busardo","year":"2015","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"10.1016\/j.jfma.2018.06.005_bib17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s40263-016-0402-z","article-title":"Pharmacological treatment in gamma-hydroxybutyrate (GHB) and gamma-butyrolactone (GBL) dependence: detoxification and relapse prevention","volume":"31","author":"Kamal","year":"2017","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.jfma.2018.06.005_bib18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1017\/S1481803500010034","article-title":"Withdrawal from gamma-hydroxybutyrate, 1,4-butanediol and gamma-butyrolactone: a case report and systematic review","volume":"10","author":"Wojtowicz","year":"2008","journal-title":"CJEM"},{"issue":"2","key":"10.1016\/j.jfma.2018.06.005_bib19","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1360-0443.2010.03145.x","article-title":"Gamma-butyrolactone (GBL) dependence and withdrawal","volume":"106","author":"Bell","year":"2011","journal-title":"Addiction"},{"issue":"11","key":"10.1016\/j.jfma.2018.06.005_bib20","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1360-0443.1989.tb00737.x","article-title":"Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar)","volume":"84","author":"Sullivan","year":"1989","journal-title":"Br J Addict"},{"issue":"10","key":"10.1016\/j.jfma.2018.06.005_bib21","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1001\/archinte.162.10.1117","article-title":"Symptom-triggered vs fixed-schedule doses of benzodiazepine for alcohol withdrawal: a randomized treatment trial","volume":"162","author":"Daeppen","year":"2002","journal-title":"Arch Intern Med"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092966461830127X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092966461830127X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T11:34:58Z","timestamp":1543404898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092966461830127X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":21,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S092966461830127X"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2018.06.005","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical management of gamma-hydroxybutyrate (GHB) withdrawal delirium with CIWA-Ar protocol","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2018.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}